News
1h
Verywell Health on MSNDangerous Side Effects and Risks of 8 Popular SupplementsSupplements are part of the daily routine for over half of adults in the United States. However, they aren't regulated in ...
The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...
Botox is a prescription drug that treats a variety of conditions, including migraine, limb spasticity, and bladder problems. Learn about common, mild, and serious side effects and how to manage them.
Kesimpta, which is used to treat multiple sclerosis, can cause side effects. Learn about its mild and serious side effects and how to manage them.
1d
Discover Magazine on MSNOzempic and Other GLP-1 Side Effects May Outweigh the BenefitsG lucagon-like peptide-1 receptor agonists (GLP-1RA) drugs, such as Ozempic and Wegovy, are often referred to as "miracle ...
2d
News Medical on MSNNew TB drugs show promise with fewer side effects than linezolidThe drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...
A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...
21h
Verywell Health on MSNWhat Happens to Your Hair When You Take Weight-Loss Medications?Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.
[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...
3d
Everyday Health on MSN9 Signs Your Compounded GLP-1 Supplier Is ShadySome online pharmacies sell semaglutide and tirzepatide that are ineffective, unsafe, or an outright scam. Here’s how to find ...
After Decades Without Progress in Glioblastoma, Diakonos Stirs Up Interest in Dendritic Cell Vaccine
The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results